Clinical Trial Update: Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 evaluation of the brain CB1 receptor PET radiotracer [18F]MK-9470 in Parkinson's disease patients and healthy volunteers was completed to assess imaging…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• [18F]MK-9470 (MK-9470 radiotracer)

Snippet

Sponsor: Institute for Neurodegenerative Disorders | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED